Top Markets
#1 Pleasing Gold Pleasing Gold +1,498.45%
#2 Ontology Gas Ontology Gas +151.18%
#3 PulseChain PulseChain +57.64%
#4 ConstitutionDAO ConstitutionDAO +37.98%
#5 BOOK OF MEME BOOK OF MEME +31.10%
#6 Neiro Neiro +29.12%
#7 Collect on Fanable Collect on Fanable +28.84%
#8 Unit Pump Unit Pump +27.30%
#9 Pump.fun Pump.fun +27.30%
#10 Ontology Ontology +27.09%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Filana Therapeutics, Inc. Filana Therapeutics, Inc.

Filana Therapeutics, Inc.

FLNA
Classifica tra le azioni #25883
Filana Therapeutics, Inc. is a company dedicated to pioneering new... Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Prezzo delle azioni
$0.9406
Capitalizzazione di mercato
$45.44M
Variazione (1 giorno)
-2.65%
Variazione (1 anno)
-
Paese
US
Scambia Filana Therapeutics, Inc. (FLNA)

Categoria

Healthcare
Rapporto P/S per Filana Therapeutics, Inc. (FLNA)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Filana Therapeutics, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Filana Therapeutics, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US